BIT:1BAYN - Euronext Milan - DE000BAY0017 - Common Stock - Currency: EUR
BIT:1BAYN (3/7/2025, 7:00:00 PM)
23.4
-1.43 (-5.76%)
The current stock price of 1BAYN.MI is 23.4 EUR. In the past month the price increased by 8.58%. In the past year, price decreased by -17.89%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1LLY.MI | ELI LILLY & CO | 67 | 760.43B | ||
LLY.DE | ELI LILLY & CO | 66.98 | 760.15B | ||
ZEG.DE | ASTRAZENECA PLC | 21.82 | 446.45B | ||
JNJ.DE | JOHNSON & JOHNSON | 16.81 | 372.31B | ||
1JNJ.MI | JOHNSON & JOHNSON | 16.61 | 367.98B | ||
NOV.DE | NOVO NORDISK A/S-B | 26.21 | 355.97B | ||
SNW.DE | SANOFI | 14.32 | 275.64B | ||
SAN.PA | SANOFI | 14.27 | 274.84B | ||
1SAN.MI | SANOFI | 14.19 | 273.18B | ||
6MK.DE | MERCK & CO. INC. | 12.64 | 224.82B | ||
1MRKX.MI | MERCK & CO. INC. | 12.47 | 221.79B | ||
PFE.DE | PFIZER INC | 8.69 | 140.81B |
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 100,873 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.
BAYER AG-REG
Kaiser-Wilhelm-Allee 1
Leverkusen NORDRHEIN-WESTFALEN DE
Employees: 96567
Company Website: https://www.bayer.com/
Investor Relations: http://www.bayer.com/en/investors
Phone: 49214301
The current stock price of 1BAYN.MI is 23.4 EUR. The price decreased by -5.76% in the last trading session.
The exchange symbol of BAYER AG-REG is 1BAYN and it is listed on the Euronext Milan exchange.
1BAYN.MI stock is listed on the Euronext Milan exchange.
28 analysts have analysed 1BAYN.MI and the average price target is 27.78 EUR. This implies a price increase of 18.7% is expected in the next year compared to the current price of 23.4. Check the BAYER AG-REG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BAYER AG-REG (1BAYN.MI) has a market capitalization of 22.99B EUR. This makes 1BAYN.MI a Large Cap stock.
BAYER AG-REG (1BAYN.MI) currently has 96567 employees.
BAYER AG-REG (1BAYN.MI) has a support level at 21.24 and a resistance level at 24.83. Check the full technical report for a detailed analysis of 1BAYN.MI support and resistance levels.
The Revenue of BAYER AG-REG (1BAYN.MI) is expected to grow by 0.12% in the next year. Check the estimates tab for more information on the 1BAYN.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BAYER AG-REG (1BAYN.MI) has a dividend yield of 0.44%. The yearly dividend amount is currently 2.42. Check the full fundamental report for a detailed analysis of 1BAYN.MI dividend history, reliability and sustainability.
BAYER AG-REG (1BAYN.MI) will report earnings on 2025-05-13.
The PE ratio for BAYER AG-REG (1BAYN.MI) is 5.49. This is based on the reported non-GAAP earnings per share of 4.26 and the current share price of 23.4 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1BAYN.MI.
ChartMill assigns a technical rating of 5 / 10 to 1BAYN.MI. When comparing the yearly performance of all stocks, 1BAYN.MI is a bad performer in the overall market: 60.12% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI. 1BAYN.MI may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months 1BAYN.MI reported a non-GAAP Earnings per Share(EPS) of 4.26. The EPS decreased by -33.41% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.82% | ||
ROE | -2.88% | ||
Debt/Equity | 1.2 |
ChartMill assigns a Buy % Consensus number of 67% to 1BAYN.MI. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 10.52% and a revenue growth 0.12% for 1BAYN.MI